Correlation Between Novan and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Novan and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novan and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novan Inc and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Novan and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novan with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novan and Tarsus Pharmaceuticals.
Diversification Opportunities for Novan and Tarsus Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Novan and Tarsus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Novan Inc and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Novan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novan Inc are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Novan i.e., Novan and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Novan and Tarsus Pharmaceuticals
If you would invest (100.00) in Novan Inc on December 2, 2024 and sell it today you would earn a total of 100.00 from holding Novan Inc or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Novan Inc vs. Tarsus Pharmaceuticals
Performance |
Timeline |
Novan Inc |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Tarsus Pharmaceuticals |
Novan and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Novan and Tarsus Pharmaceuticals
The main advantage of trading using opposite Novan and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novan position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.Novan vs. Tarsus Pharmaceuticals | Novan vs. Aldeyra | Novan vs. Travere Therapeutics | Novan vs. Eton Pharmaceuticals |
Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |